Insilico Medicine advances AI drug for IPF to Phase III trials
🔒
https://artificialintelligence-news.com
«Insilico Medicine is advancing to Phase III human trials for testing a drug identified by AI targeting idiopathic pulmonary fibrosis (IPF). This progression supplies the computational drug discovery sector with empirical...»
Automatische Weiterleitung...
1.5s